| # | Drug | Count |
|---|---|---|
| 0 | ZOLEDRONIC ACID | 9 |
| 1 | TOPIRAMATE | 6 |
| 2 | ALENDRONATE SODIUM | 5 |
| 3 | OMEPRAZOLE | 5 |
| 4 | OMEPRAZOLE MAGNESIUM | 5 |
| 5 | ESOMEPRAZOLE MAGNESIUM | 4 |
| 6 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 3 |
| 7 | BICALUTAMIDE | 3 |
| 8 | CONJUGATED ESTROGENS | 3 |
| 9 | ESOMEPRAZOLE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 3 | 0.0011 |
| 1 | TRIPTORELIN | 3 | 0.0009 |
| 2 | PENTAMIDINE ISETHIONATE | 1 | 0.0008 |
| 3 | DEFERIPRONE | 1 | 0.0003 |
| 4 | ZOLEDRONIC ACID | 9 | 0.0002 |
| 5 | BICALUTAMIDE | 3 | 0.0002 |
| 6 | GEMFIBROZIL | 2 | 0.0002 |
| 7 | ACLIDINIUM BROMIDE | 1 | 0.0002 |
| 8 | SPARSENTAN | 1 | 0.0001 |
| 9 | VANCOMYCIN HYDROCHLORIDE | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Proton Pump Inhibitor [EPC] | 6 |
| 1 | Corticosteroid [EPC] | 5 |
| 2 | Vitamin D [EPC] | 4 |
| 3 | Androgen Receptor Inhibitor [EPC] | 3 |
| 4 | Angiotensin 2 Receptor Blocker [EPC] | 3 |
| 5 | Estrogen [EPC] | 3 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 3 |
| 7 | Platinum-based Drug [EPC] | 3 |
| 8 | Benzodiazepine [EPC] | 2 |
| 9 | Calcium [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lipid-based Polyene Antifungal [EPC] | 1 | 0.0001 |
| 1 | Intestinal Lipase Inhibitor [EPC] | 1 | 0.0000 |
| 2 | Epidermal Growth Factor Receptor Antagonist [EPC] | 2 | 0.0000 |
| 3 | Antimycobacterial [EPC] | 1 | 0.0000 |
| 4 | Androgen Receptor Inhibitor [EPC] | 3 | 0.0000 |
| 5 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 2 | 0.0000 |
| 6 | Iron Chelator [EPC] | 1 | 0.0000 |
| 7 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 8 | Polyene Antifungal [EPC] | 1 | 0.0000 |
| 9 | Histamine-1 Receptor Antagonist [EPC] | 2 | 0.0000 |